CRONOS GROUP INC. Increase (Decrease) in Accounts Receivable
CRONOS GROUP INC. (CRON) reported Increase (Decrease) in Accounts Receivable of $2.69 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-06
- CRONOS GROUP INC. increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was $3.57M, a 44.03% decline year-over-year.
- CRONOS GROUP INC. increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was -$879.00K, a 125.78% decline year-over-year.
- CRONOS GROUP INC. increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was $6.23M.
- CRONOS GROUP INC. increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was $716.00K, a 73.27% decline year-over-year.
- CRONOS GROUP INC. increase (decrease) in accounts receivable for fiscal 2025 was $16.74M, a 1725.63% increase from fiscal 2024.
- CRONOS GROUP INC. increase (decrease) in accounts receivable for fiscal 2024 was $917.00K.
- CRONOS GROUP INC. increase (decrease) in accounts receivable for fiscal 2023 was -$9.21M, a 439.58% decline from fiscal 2022.
- CRONOS GROUP INC. increase (decrease) in accounts receivable for fiscal 2022 was $2.71M, a 79.40% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 3 month as first filed | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 6 month as first filed | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 9 month as first filed | Increase (Decrease) in Accounts Receivable 12 month | Increase (Decrease) in Accounts Receivable 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $3.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $2.69M 10-Q · filed 2026-08-06 | $8.93M derived: sum of 3 quarters · filed 2026-08-06 | $9.64M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | -$879.00K 10-Q · filed 2026-05-11 | $5.35M derived: sum of 2 quarters · filed 2026-05-11 | $6.07M derived: sum of 3 quarters · filed 2026-05-11 | $12.45M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | $6.23M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $6.95M derived: sum of 2 quarters · filed 2026-02-26 | $13.33M derived: sum of 3 quarters · filed 2026-08-06 | $16.74M 10-K · filed 2026-02-26 | ||||
| 2025-09-30 | $716.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $7.10M derived: sum of 2 quarters · filed 2026-08-06 | $10.51M 10-Q · filed 2025-11-06 | $6.03M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $6.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $9.79M 10-Q · filed 2026-08-06 | $5.31M derived: sum of 3 quarters · filed 2026-08-06 | $7.99M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | $3.41M 10-Q · filed 2026-05-11 | -$1.08M derived: sum of 2 quarters · filed 2026-05-11 | $1.60M derived: sum of 3 quarters · filed 2026-05-11 | $2.67M derived: sum of 4 quarters · filed 2026-05-11 | ||||
| 2024-12-31 | -$4.49M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$1.81M derived: sum of 2 quarters · filed 2026-02-26 | -$737.00K derived: sum of 3 quarters · filed 2026-02-26 | $917.00K 10-K · filed 2026-02-26 | ||||
| 2024-09-30 | $2.68M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $3.75M derived: sum of 2 quarters · filed 2025-11-06 | $5.40M 10-Q · filed 2025-11-06 | $3.17M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-06-30 | $1.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $2.72M 10-Q · filed 2025-08-07 | $493.00K derived: sum of 3 quarters · filed 2026-02-26 | $4.14M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-03-31 | $1.65M 10-Q · filed 2025-05-08 | -$576.00K derived: sum of 2 quarters · filed 2026-02-26 | $3.07M derived: sum of 3 quarters · filed 2026-02-26 | $649.00K derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2023-12-31 | -$2.23M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.42M derived: sum of 2 quarters · filed 2026-02-26 | -$1.00M derived: sum of 3 quarters · filed 2026-02-26 | -$9.21M 10-K · filed 2026-02-26 | ||||
| 2023-09-30 | $3.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $1.23M derived: sum of 2 quarters · filed 2024-11-12 | -$6.98M 10-Q · filed 2024-11-12 | -$3.09M derived: sum of 4 quarters · filed 2025-02-27 | ||||
| 2023-06-30 | -$2.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$10.62M 10-Q · filed 2024-08-08 | -$6.74M derived: sum of 3 quarters · filed 2025-02-27 | -$5.93M derived: sum of 4 quarters · filed 2025-02-27 | ||||
| 2023-03-31 | -$8.20M 10-Q · filed 2024-05-09 | -$4.32M derived: sum of 2 quarters · filed 2025-02-27 | -$3.51M derived: sum of 3 quarters · filed 2025-02-27 | -$9.02M derived: sum of 4 quarters · filed 2025-02-27 | ||||
| 2022-12-31 | $3.88M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $4.69M derived: sum of 2 quarters · filed 2025-02-27 | -$819.00K derived: sum of 3 quarters · filed 2025-02-27 | $2.71M 10-K · filed 2025-02-27 | ||||
| 2022-09-30 | $809.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$4.70M derived: sum of 2 quarters · filed 2023-11-08 | -$1.17M 10-Q · filed 2023-11-08 | $6.24M derived: sum of 4 quarters · filed 2024-02-29 | ||||
| 2022-06-30 | -$5.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | -$1.98M 10-Q · filed 2023-08-08 | $5.43M derived: sum of 3 quarters · filed 2024-02-29 | $8.99M derived: sum of 4 quarters · filed 2024-02-29 | ||||
| 2022-03-31 | $3.53M 10-Q · filed 2023-05-09 | $10.95M derived: sum of 2 quarters · filed 2024-02-29 | $14.50M derived: sum of 3 quarters · filed 2024-02-29 | $18.62M derived: sum of 4 quarters · filed 2024-02-29 | ||||
| 2021-12-31 | $7.42M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $10.97M derived: sum of 2 quarters · filed 2024-02-29 | $15.09M derived: sum of 3 quarters · filed 2024-02-29 | $13.16M 10-K · filed 2024-02-29 | ||||
| 2021-09-30 | $3.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | $7.68M derived: sum of 2 quarters · filed 2022-11-07 | $5.75M 10-Q · filed 2022-11-07 | $10.73M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-06-30 | $4.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $2.19M 10-Q · filed 2022-08-09 | $7.18M derived: sum of 3 quarters · filed 2023-02-28 | $9.81M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-03-31 | -$1.93M 10-Q · filed 2022-05-10 | $3.06M derived: sum of 2 quarters · filed 2023-02-28 | $5.69M derived: sum of 3 quarters · filed 2023-02-28 | $3.27M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2020-12-31 | $4.99M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $7.62M derived: sum of 2 quarters · filed 2023-02-28 | $5.20M derived: sum of 3 quarters · filed 2023-02-28 | $4.72M 10-K · filed 2023-02-28 | ||||
| 2020-09-30 | $2.63M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2022-02-18 | $210.00K derived: sum of 2 quarters · filed 2022-02-18 | -$262.00K 10-Q · filed 2022-02-18 | $1.45M 10-Q · filed 2020-11-05 | -$1.69M derived: sum of 4 quarters · filed 2022-03-01 | |||
| 2020-06-30 | -$2.42M derived: 10-Q/A 6 month − 10-Q 3 month · filed 2022-02-18 | -$2.90M 10-Q/A · filed 2022-02-18 | -$1.16M 10-Q · filed 2020-08-06 | -$4.32M derived: sum of 3 quarters · filed 2022-03-01 | -$6.32M derived: sum of 4 quarters · filed 2022-03-01 | |||
| 2020-03-31 | -$472.00K 10-Q · filed 2021-05-07 | -$1.23M 10-Q · filed 2020-05-08 | -$1.90M derived: sum of 2 quarters · filed 2022-03-01 | -$3.89M derived: sum of 3 quarters · filed 2022-03-01 | $1.08M derived: sum of 4 quarters · filed 2022-03-01 | |||
| 2019-12-31 | -$1.43M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$3.42M derived: sum of 2 quarters · filed 2022-03-01 | $1.55M derived: sum of 3 quarters · filed 2022-03-01 | $566.00K 10-K · filed 2022-03-01 | $702.00K 10-K/A · filed 2020-03-30 | |||
| 2019-09-30 | -$2.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $2.98M derived: sum of 2 quarters · filed 2020-11-05 | $1.99M 10-Q · filed 2020-11-05 | |||||
| 2019-06-30 | $4.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $3.99M 10-Q · filed 2020-08-06 | ||||||
| 2019-03-31 | -$984.00K 10-Q · filed 2020-05-08 | |||||||
| 2018-12-31 | $2.57M 10-K · filed 2021-02-26 | |||||||
| 2017-12-31 | $3.20M 10-K/A · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |